[20160829]IF10463_非处方药监管.pdf

上传人:任我行 文档编号:25935 上传时间:2022-06-24 发布时间:2019-06-25 格式:PDF 页数:3 大小:418.24KB
下载 相关 举报
[20160829]IF10463_非处方药监管.pdf_第1页
第1页 / 共3页
[20160829]IF10463_非处方药监管.pdf_第2页
第2页 / 共3页
[20160829]IF10463_非处方药监管.pdf_第3页
第3页 / 共3页
亲,该文档总共3页,全部预览完了,如果喜欢就下载吧!
资源描述

1、 https:/crsreports.congress.gov August 29, 2016Regulation of Over-the-Counter (OTC) DrugsThe Food and Drug Administration (FDA) regulates the safety and effectiveness of drug products sold in the United States. FDAs regulatory authority covers both prescription and nonprescription (i.e., over-the-co

2、unter, or OTC) drugs, among other things. Legislative Background The Pure Food and Drug Act of 1906 prohibited the interstate commerce of adulterated and misbranded drugs, but it did not provide FDA with the authority to review and approve products before they enter the market. Thus, drugs introduce

3、d between 1906 and 1938 were considered “pure” but with unknown safety and effectiveness. In 1938, Congress passed the Federal Food, Drug, and Cosmetic Act (FFDCA), which authorized FDA to regulate the safety of drug products sold in the United States. In 1951, the FFDCA was amended to include a pre

4、scription-only category of drugs. While prescription drugs require health practitioner supervision (due to drug toxicity, potential harmful effect, and/or method of use), OTC drugs can be used without a prescribers authorization, provided that they have an acceptable safety margin, low potential for

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告